Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Risk Factors and Prediction of Acute Kidney Injury in Hospitalized Urology Patients: A Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

Comparative Analysis of Robotic and Laparoscopic Partial Nephrectomy: Insights Into Precision and Efficiency.

Advances in urology·2026
Same author

Impact of the AirSeal<sup>®</sup> insufflation system on perioperative outcomes in robotic partial nephrectomy: a comparative cohort study.

Journal of robotic surgery·2026
Same author

Robotic Vessel Sealer vs. Robotic Bipolar Grasper in Partial Nephrectomy.

Cancers·2026
Same author

Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation-a narrative review from EAU endourology.

World journal of urology·2026
Same author

Thulium Fiber Laser Versus Holmium:YAG for Urological Stone Lithotripsy: A Systematic Review and Meta-Analysis.

Photobiomodulation, photomedicine, and laser surgery·2026

相关实验视频

Updated: Jan 7, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.9K

在高R.E.N.A.L.中出现了类和侵略性变体. 评分T1b RCC: laparoscopic和机器人激进切除术后的结果

Murad Asali1,2, Galeb Asali3, Ron Batash4

  • 1Urology Department, Barzilai Medical Center, Ben Gurion University of the Negev, Beer Sheva 8430905, Israel.

Cancers
|December 30, 2025
PubMed
概括
此摘要是机器生成的。

腹腔镜激进切除术 (LRN) 对T1b细胞癌 (RCC) 具有高RENALL的安全. 提供良好的瘤控制和保持功能. 具有侵略性的病理特征是常见的,支持这些复杂病例的LRN.

关键词:
这就是R.E.N.A.L.L.的意义. 计计分数的得分是多少T1b RCC RCC 的时间表.腹腔镜外科手术 腹腔镜外科手术进行激进性切除术.细胞癌瘤是细胞癌.维护功能 维护功能

更多相关视频

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

17.2K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.3K

相关实验视频

Last Updated: Jan 7, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.9K
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

17.2K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.3K

科学领域:

  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 在瘤学瘤学.
  • 手术病理学手术病理学

背景情况:

  • 管理T1b细胞癌 (RCC) 与中度至高RENAL的治疗. 神经测量得分带来了一些挑战.
  • 虽然部分切除术可以保持功能,但对于复杂瘤的最佳手术方法仍在争论中.

研究的目的:

  • 为了评估腹腔镜彻底切除术 (LRN) 对T1bRCC的结果,中度至高RENALL. 的分数 (≥8).
  • 评估这些病例中sarcomatoid和其他侵略性病理变异的发病率和预后影响.

主要方法:

  • 对118名接受T1b RCC与R.E.N.A.L.L.R.N.治疗的患者进行了回顾性分析. 评分≥8 (2008-2024年) 的情况.
  • 主要结局:术后并发症,功能维护和病理发现.
  • 随访包括实验室检查,超声波和CT扫描,直至术后30个月.

主要成果:

  • 这意味着R.E.N.A.L.L. 平均瘤直径为6.0厘米 (CT) /4.7厘米 (病理).
  • 平均手术时间:151.6分钟;平均血液损失:75.2毫升;并发症率:7.6% (9/118).
  • 在29.7%的病例中发现了侵略性的病理特征 (高度,多种瘤,变体).

结论:

  • LRN是T1b RCC中适度至高RENAL的安全有效选择. 一个分数,一个分数.
  • LRN提供了足够的瘤控制和可接受的功能保存.
  • 攻击性特征的高发病率支持这个队列中的激进切除术.